erythrohydrobupropion

erythrohydrobupropion is a chemical compound that is a metabolite of bupropion, an antidepressant and smoking cessation aid. Bupropion is a norepinephrine-dopamine reuptake inhibitor. When bupropion is metabolized in the body, it is converted into several other compounds, and erythrohydrobupropion is one of these. The "erythro" prefix refers to the specific stereochemical arrangement of the hydroxyl and amino groups on the molecule. This particular isomer is formed through the reduction of the carbonyl group in bupropion and the subsequent addition of a hydroxyl group. The formation of erythrohydrobupropion is primarily carried out by enzymes in the liver. Its pharmacological activity is generally considered to be less significant than that of bupropion itself or other major metabolites like hydroxybupropion. However, understanding the metabolic pathways and the resulting metabolites of bupropion is important for comprehending its overall pharmacokinetic profile and potential drug interactions. Research into the specific contributions of erythrohydrobupropion to bupropion's therapeutic effects or side effects is limited.